Getinge Ab Class B · OMXSTO:GETI_B
Getinge Ab Class B — Corporate Update (June 2022)
7 slides from Getinge Ab Class B's corporate update, Jun 14, 2022
Slide 1: Getinge revises down outlook for 2022 – long-term financial targets unchanged
Getinge revises down outlook for 2022 – long-term financial targets unchanged June 14, 2022
Slide 2: Key take-aways
Key take-aways • New outlook: organic net sales for 2022 in line with actual outcome in net sales for 2021 • Previous outlook: upper end of the range of 4-6% organic growth • Getinge’s financial position is expected to remain strong • Getinge's financial targets through 2025 remain unchanged Getinge
Slide 3: Main reasons for new outlook
Main reasons for new outlook • Mild flu season – impacting sales of products for ECMO-therapy negatively • Reduced production of COVID-19 vaccines • Supply chain disruptions • Russia’s invasion of Ukraine Getinge revises down its outlook for 2022 14 June 2022 Page 3
Slide 4: Getinge's financial targets through 2025 remain unchanged
Getinge's financial targets through 2025 remain unchanged • Organic net sales: 4-6% annual growth on average • Adj EPS: >10% annual growth on average • Adj EBITA margin 2025 as an outcome of the two targets: >21% Getinge revises down its outlook for 2022 14 June 2022 Page 4
Slide 5: Q&A
Q&A Getinge revises down its outlook for 2022 14 June 2022 Page 5
Slide 6: GETINGE
“= Se A GETINGE PASSION FOR LIFE
Slide 7: Forward looking information
Forward looking information This document contains forward-looking information based on the current expectations of the Getinge’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectation
Getinge — Corporate Update (June 2022) on 6ix